Neurology News and Research

Latest Neurology News and Research

Gabapentin medication induces anorgasmia in older and elderly patients

Boston University School of Medicine (BUSM) researchers have found that Gabapentin, a medication commonly used to treat neuropathic pain, seizures and biopolar disease in older and elderly patients, seems to have a higher incidence of anorgasmia, or failure to experience orgasm, than previously reported. This study appears in the current issue of the American Journal of Geriatric Pharmacotherapy.

4 Jun 2011

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

Mount Sinai Medical Center in Miami Beach, Florida announced its participation in the Medtronic CoreValve U.S. Clinical Trial, which will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis. Mount Sinai is now among a select number of leading hospitals across the U.S. to participate in this trial.

From Medtronic 4 Jun 2011

Insight into beneficial epilepsy treatments for children with autism

Physicians will have a better guide for more effectively managing treatment of children experiencing seizures related to autism with the results of a study by researchers at Arizona State University and the University of Texas-Houston.

3 Jun 2011

UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005

In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.

3 Jun 2011

Mild brain injury tracked using special MRI technique

According to a new study there may be an explanation of why some military personnel exposed to blasts have symptoms of brain injury even though their CT and MRI scans look normal.

2 Jun 2011

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.

2 Jun 2011

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Repligen Corporation today announced that the Company has concluded a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration related to its lead product candidate, RG1068 for improvement of magnetic resonance imaging of the pancreas.

2 Jun 2011

Baseline concussion tests could increase risks to athletes

Baseline concussion tests given to hundreds of thousands of athletes might, paradoxically, increase risks in some cases, according to a Loyola University Health System researcher.

2 Jun 2011

Study finds notable prevalence of childhood abuse in migraine patients

A notable prevalence of childhood abuse - physical, sexual, verbal, or emotional - in migraine patients has been observed and documented over the last few years. In fact, it has emerged as a significant enough issue for the American Headache Society to devote an entire plenary session to it at its annual scientific conference in Washington this week.

2 Jun 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results of a Phase II single-arm study to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's lenvatinib demonstrated an Objective Response Rate of 59% (34/58, 95% CI: 45-71), based on an updated investigator assessment, in patients with advanced radioiodine (RAI)-refractory differentiated thyroid cancer.

1 Jun 2011

FTC accepts Grifols and Talecris' Consent Agreement for public comment

Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. announced today that the U.S. Federal Trade Commission has accepted for public comment a Consent Agreement that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed.

1 Jun 2011

Non-invasive trigeminal nerve stimulation shows promise for drug-resistant epilepsy

Medications are the mainstay of treatment for epilepsy, but for a considerable number of patients — estimated to be as many as 1 million in the U.S. — drugs don't work. These patients suffer from a type of epilepsy known as refractory or drug-resistant epilepsy, in which drugs can't control their seizures.

1 Jun 2011

School children with bullying behavior more likely to have sleep-disordered breathing

Children who are bullies or have conduct problems at school, are more likely to be sleepy during the day according to University of Michigan Medical School researchers.

1 Jun 2011

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

After years of building hope for a treatment, Rochester researchers and clinicians will begin the first controlled clinical trial for Juvenile Batten disease this summer, thanks to $1 million in grants from the Food and Drug Administration and the Batten Disease Support and Research Association.

1 Jun 2011

Cell phones and cancer – link established

In its latest announcement the World Health Organization (WHO) said that radiation from cell phones can possibly cause cancer. According to the WHO's International Agency for Research on Cancer (IARC), radiofrequency electromagnetic fields have been classified as possibly carcinogenic to humans (group 2B) on the basis of an increased risk for glioma that some studies have associated with the use of wireless phones.

1 Jun 2011

Increased stress not linked to multiple sclerosis

According to a new study that refutes earlier evidence, stress does not appear to increase a person's risk of developing multiple sclerosis (MS). The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

31 May 2011

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

Affymax, Inc. and Takeda Pharmaceutical Company Limited today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the investigational agent peginesatide for the treatment of anemia associated with chronic renal failure in adult patients on dialysis.

31 May 2011

Stress does not appear to increase risk of developing multiple sclerosis

Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

31 May 2011

HHS uses new devices to meet growing need of joint replacements among baby boomers

"The number of patients in their 50s coming into my office asking for joint replacement is higher than ever," says Dr. Steven B. Haas, a knee surgeon at Hospital for Special Surgery in New York City.

30 May 2011

ENS, SSIF announce prestigious award to recognize excellence in medical education

Serono Symposia International Foundation (SSIF) has announced today a public competition for an Award to recognise an expert in the field of neurology who has made a significant contribution to medical education activities through research and dedication.

30 May 2011

Neurology News and Research

Latest Neurology News and Research

Gabapentin medication induces anorgasmia in older and elderly patients

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

Insight into beneficial epilepsy treatments for children with autism

UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005

Mild brain injury tracked using special MRI technique

Diffusion tensor imaging detects brain abnormalities in U.S. military personnel with mild traumatic brain injury

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Baseline concussion tests could increase risks to athletes

Study finds notable prevalence of childhood abuse in migraine patients

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

FTC accepts Grifols and Talecris' Consent Agreement for public comment

Non-invasive trigeminal nerve stimulation shows promise for drug-resistant epilepsy

School children with bullying behavior more likely to have sleep-disordered breathing

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

Cell phones and cancer – link established

Increased stress not linked to multiple sclerosis

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

Stress does not appear to increase risk of developing multiple sclerosis

HHS uses new devices to meet growing need of joint replacements among baby boomers

ENS, SSIF announce prestigious award to recognize excellence in medical education

Innovation in neuroscience drug discovery - eBook eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Neurology News and Research

Latest Neurology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in